Prevalence of Respiratory Complications In Covid-19 Patients

Background & Objective: In 2019 COVID-19 virus was emerged from China which was then declared a pandemic by WHO. This virus affects different organs of the body and causes some serious complications mainly affecting the respiratory system. The main objective of this research was to find out the prevalence of respiratory complications in patients with COVID-19. Methodology: A cross-sectional survey was conducted on patients with COVID-19 to find out the prevalence of respiratory complications in people. A sample size of 200 participants was selected using the non-probability convenience technique. The duration of the study was 6 months i.e., April to September 2021. Data was collected from Public sector hospitals situated in Rawalpindi and Islamabad in the form of hard copies. The tools used for the data collection were the CAP scale, MMRC scale for dyspnea, and CAT scale. The collected data was analyzed using SPSS Statistics V23.0. Results: Out of 200 participants, 111(55.5%) were male and 89 (44.5%) were females. The mean values of Community-acquired pneumonia (CAP) scale, Modified Medical Research Council (MMRC) scale for dyspnea and COPD Assessment Test (CAT) scale are 48.3, 3.02 and 26.09. Out of 200 participants Dyspnea was prevalent in 77.5% of people, Pneumonia was prevalent in 68% of people and COPD was prevalent in 56% of people. The P value for the three groups including CAP, MMRC and CAT is less than 0.05 (P < 0.05) which indicates that results are statistically significant. Conclusion: The findings indicate that there is a prevalence of Respiratory complications in COVID-19 Patients. Results are statistically significant as P value is P < 0.05